FREDUN

Fredun Pharmaceuticals Share PriceFredun Pharmaceuticals

₹865.00
13.75 (1.62%)
As on 22 March, 2023 | 04:43 BSE: 539730 NSE: FREDUN

Fredun Pharmaceuticals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Fredun Pharmaceuticals

Start SIP

Fredun Pharmaceuticals Share Price

  • Over 1 Month -9.59%
  • Over 3 Month -28.87%
  • Over 6 Month -14.89%
  • Over 1 Year -13.55%

Fredun Pharmaceuticals Key Statistics

Fredun Pharmaceuticals Investment Rating

  • Master Rating:
  • Fredun Pharmaceuticals has an operating revenue of Rs. 264.06 Cr. on a trailing 12-month basis. An annual revenue growth of 67% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 9% is fair but needs improvement. The company has a debt to equity of 62%, which is bit higher. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Fredun Pharmaceuticals Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 78694869
Operating Expenses Qtr Cr 71644566
Operating Profit Qtr Cr 7543
Depreciation Qtr Cr 1111
Interest Qtr Cr 2222
Tax Qtr Cr 1101
Net Profit Qtr Cr 3312

Fredun Pharmaceuticals Technicals

EMA & SMA

Current Price
₹865.
13.75 (1.62%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 886.01
  • 50 Day
  • 959.48
  • 100 Day
  • 1017.62
  • 200 Day
  • 1010.4
  • 20 Day
  • 882.69
  • 50 Day
  • 965.88
  • 100 Day
  • 1098
  • 200 Day
  • 1040.73

Fredun Pharmaceuticals Resistance and Support

PIVOT
₹859.85
Resistance
First Resistance 889.7
Second Resistance 928.15
Third Resistance 958
RSI 41.64
MFI 35.91
MACD Single Line -39.1
MACD -38.54
Support
First Resistance 821.4
Second Resistance 791.55
Third Resistance 753.1

Fredun Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 1,912 140,800 73.64
Week 4,061 352,216 86.74
1 Month 3,346 266,992 79.8
6 Month 2,887 223,723 77.49

Fredun Pharmaceuticals Result Highlights

Fredun Pharmaceuticals Synopsis

BSE-Medical-Diversified

Fredun Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 224.46 Cr. and Equity Capital is Rs. 4.43 Cr. for the Year ended 31/03/2022. Fredun Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 08/06/1987 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1987PLC043662 and registration number is 043662.
Market Cap 388
Sales 264
Shares in Float 0.23
No of funds 1
Yield 0.08
Book Value 5.63
U/D Vol ratio 0.5
LTDebt / Equity 62
Alpha 0.01
Beta 1.01

Fredun Pharmaceuticals

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 50.34%51.04%51.04%
Financial Institutions/ Banks 1.66%1.68%1.68%
Individual Investors 42.48%42.02%42.02%
Others 5.52%5.26%5.26%

Fredun Pharmaceuticals Management

Name Designation
Dr.(Mrs.) Daulat N Medhora Chairman & Jt. M. D
Mr. Fredun Medhora Managing Director & CFO
Mr. Nariman Medhora Non Executive Director
Dr. Chandrakant Shah Ind. Non-Executive Director
Dr. Rohinton Kanga Ind. Non-Executive Director
Dr. Aspi Raimalwala Ind. Non-Executive Director

Fredun Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Fredun Pharmaceuticals FAQs

What is Share Price of Fredun Pharmaceuticals ?

Fredun Pharmaceuticals share price is ₹865 As on 22 March, 2023 | 04:29

What is the Market Cap of Fredun Pharmaceuticals ?

The Market Cap of Fredun Pharmaceuticals is ₹392 Cr As on 22 March, 2023 | 04:29

What is the P/E ratio of Fredun Pharmaceuticals ?

The P/E ratio of Fredun Pharmaceuticals is 39.8 As on 22 March, 2023 | 04:29

What is the PB ratio of Fredun Pharmaceuticals ?

The PB ratio of Fredun Pharmaceuticals is 5.8 As on 22 March, 2023 | 04:29

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number